
Panel members are asked to discuss what drives the cost of drugs in cancer care. They also discuss the role companion diagnostics and personalized medicine play in oncology.

Panel members are asked to discuss what drives the cost of drugs in cancer care. They also discuss the role companion diagnostics and personalized medicine play in oncology.

AJMC's Co-Editor-in-Chief, Michael E. Chernew, PhD, Lee N. Newcomer, MD, MHA, UnitedHealthcare, and Sandra M. Swain, MD, Washington Cancer Institute, Medstar Washington Hospital Center.





The Center for Health Value Innovation (CHVI) presented a webinar yesterday that touched on clinical pathways for oncology and how value-based approaches will help to improve health and financial outcomes.






Getting On Pathway?


Signaling the Future of Personalized Medicine


Money Well Spent?


SABCS Conference Coverage

This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.

Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy

Availability of Newer Agents May Lower Healthcare Costs

Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology


UPMC Oncologists: Pioneers in the Clinical Pathways Movement

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
